Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2004-09-17
2008-03-11
Priebe, Scott D. (Department: 1633)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C424S009200, C424S192100, C424S193100, C435S006120
Reexamination Certificate
active
07341710
ABSTRACT:
The present invention provides methods for in vivo panning of a library to identify molecules that specifically home to a selected organ.
REFERENCES:
patent: 4399124 (1983-08-01), Fauve
patent: 4897464 (1990-01-01), Vallee et al.
patent: 5081034 (1992-01-01), Bevilasqua et al.
patent: 5098833 (1992-03-01), Lasky et al.
patent: 5216131 (1993-06-01), Lasky et al.
patent: 5225538 (1993-07-01), Capon et al.
patent: 5270163 (1993-12-01), Gold et al.
patent: 5288846 (1994-02-01), Quertermous et al.
patent: 5304640 (1994-04-01), Lasky et al.
patent: 5415874 (1995-05-01), Bender et al.
patent: 5428130 (1995-06-01), Capon et al.
patent: 5453362 (1995-09-01), Lamarco et al.
patent: 5506126 (1996-04-01), Seed et al.
patent: 5622699 (1997-04-01), Ruoslahti et al.
patent: 5660827 (1997-08-01), Thorpe et al.
patent: 5688935 (1997-11-01), Stephens et al.
patent: 6068829 (2000-05-01), Ruoslahti et al.
patent: 6296832 (2001-10-01), Ruoslahti et al.
patent: 6306365 (2001-10-01), Ruoslahti et al.
patent: 7018615 (2006-03-01), Ruoslahti et al.
patent: 2101942 (2001-01-01), None
patent: 0 135 277 (1985-03-01), None
patent: 0 639 584 (1995-02-01), None
patent: WO 92/03461 (1992-03-01), None
patent: WO 92/06191 (1992-04-01), None
patent: WO 92/00091 (1992-09-01), None
patent: WO 95/14714 (1995-06-01), None
patent: WO 96/34874 (1996-11-01), None
patent: WO 96/34875 (1996-11-01), None
Altieri et al., “A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CD11b/CD18),”J. Biol Chem. 265:12119-12122 (1990).
Baillie et al., “Tumour Vasculature—A Potential Therapeutic Target,”British J. Cancer72:257-267 (1995).
Beinfield, “The Distribution and Chromatographic Characterization of An Amino-Terminal Fragment of Cholecystokinin (CCK) 58 In Rat Brain,”Biochem. Biophy. Res. Comm. 127:720-725 (1985).
Brooks et al., “Integrin αvβ3antagonists promote tumor regresson by inducing apoptosis of angiogenic blood vessels,”Cell79:1157-1164 (1994).
Burioni et al., “Recombinant Human Fab to Glycoprotein D Neutralizes Infectivity and Prevents Cell-to-Cell Transmission of Herpes Simplex Viruses 1 and 2 In Vitro,”Proc. Natl. Acad. Sci. USA91:355-359 (1994).
Burrows and Thorpe, “Vascular Targeting—A New Approach to the Therapy of Solid Tumors,”Pharmac.Ther. 64:155-174 (1994).
Burton et al., “A Large Array of Human Monoclonal Antibodies to Type 1 Human Immunodeficiency Virus From Combinatorial Libraries of Asymptomatic Seropositive Individuals,”Proc. Natl. Acad. Sci. USA88: 10134-10137 (1991).
Cattani et al., “Cloning and Characterization of Human Recombinant Antibody Fab Fragments Specific for Types 1 and 2 Herpes Simplex Virus,”Chem. Abstr. Immunochemistry123:141201m (1995).
Cattani et al., “Cloning and Characterization of Human Recombinant Antibody Fab Fragments Specific for Types 1 and 2 Herpes Simplex Virus,”Microbiologica18:135-142 (1995).
Davis et al., “Use of High Affinity DNA Ligand in Flow Cytometry,”Nucl. Acids Res. 24:702-706 (1996).
Drolet et al., “An Enzyme-linked Oligonucleotide Assay,”Nat. Biotech. 14:1021-1025 (1996).
Dvorak et al., “Structure of Solid Tumors and Their Vasculature: Implications for Therapy with Monoclonal Antibodies,”Cancer Cells3:77-85 (1991).
Fidler and Hart, “Biological diversity in metastatic neoplasms: origins and implications,”Science217:998-1003 (1982).
Goetz et al., “Lu-ECAM-1-Mediated Adhesion of Melanoma Cells Endothelium Under Conditions of Flow,”Int. J. Cancer65:192-199 (1996).
Gold et al., “Diversity of Oligonucleotide Functions,”Annu. Rev. Biochem. 64:763-797 (1995).
Goodson et al., “High-affinity Urokinase Receptor Antagonists Identified with Bacteriophage Peptide Display,”Proc. Natl. Acad. Sci. USA. 91:7129-7133 (1994).
Green et al., “Comprehensive Chemical Modification Interference and Nucleotide Substitution Analysis of an RNA Pseudoknot Inhibitor to HIV-1 Reverse Transcriptase,”J. Mol. Biol. 247:60-68 (1995).
Hart et al., “Cell binding and internalization by filamentous phage displaying a cyclic Arg-Gly-Asp-containing peptide,”J. Biol. Chem. 269:12468-12474 (1994).
Hendrikx et al., “Homing of Fluorescently labeled murine hematopoietic stem cells,”Experimental Hematology24:129-140 (1996).
Hicke et al., “DNA Aptamers Block L-Selectin Function In Vivo”J. Clin. Invest. 98:2688-2692 (1996).
Huang et al., “Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature,”Science275:547-550 (1997).
Koivunen et al., “Isolation of a highly specific ligand for the α5β1integrin from a phage display library,”J. Cell. Biol. 124: 373-380 (1994).
Koivunen et al., “Phage Libraries Displaying Cyclic Peptides with Different Ring Sizes: Ligand Specificities of the RGD-Directed Integrins,”Biotechnology13:265-270 (1995).
Koivunen et al., “Selection of Peptides Binding to the α5β1Integrin from Phage Display Library,”J. Biol. Chem. 268:20205-20210 (1993).
Koivunen et al., “Peptides in cell adhesion research,”Meth. Enzymol. 245:346-369 (1994b).
Lappi, Douglas A., “Tumor Targeting Through Fibroblast Growth Factor Receptors,”Cancer Biology6:279-288 (1995).
Leff, D., “NeXstar Previews ‘PASS’ for Downstream Synthesis of Therapeutic Oligos”Bioworld Today8:2&4 (1997).
Martiny-Baron and Marmé, “VEGF-mediated Tumour Angiogenesis: A New Target for Cancer Therapy,”Current Biology6:675-680 (1995).
Miner et al., “Clonal Drift of Cell Surface, Melanogenic, and Experimental Metastatic Properties of in vivo-selected, Brain Meninges-colonizing Murine B16 Melanoma,”Cancer Research42:4631-4638 (1982).
Mitjans et al., “An anti-αv-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice,”J. Cell Sci. 108:2925-2838 (1995).
Nakano et al., “Genetic defect in T lymphocyte-specific homing into peripheral lymph nodes,”Eur. J. Immunol. 27:215-221 (1997).
Pasqualini and Ruoslahti, “Organ Targeting in vivo Using Phage Display Peptide Libraries,”Nature380:364-366 (1996).
Pasqualini et al., “αv integrins as receptors for tumor targeting by circulating ligands,”Nature Biotech. 15:542-546 (1997).
Pauli et al., “Organ-preference of metastasis,”Cancer and Metastasis Reviews9:175-189 (1990).
Ruoslahti, “Integrins,”J. Clin. Invest. 87:1-5 (1991).
Salami et al., “Selective endothelial binding of interleukin-2-dependent human T-cell lines derived from different tissues,”Proc. Natl. Acad. Sci., USA89:11436-11440 (1992).
Schlosshauer and Herzog, “Neurothelin: an inducible cell surface glycoprotein of blood-brain barrier-specific endothelial cells and distinct neurons,”J. Cell Biol. 110:1261-1274 (1990).
Smith and Smith, “Identification of New Protein Kinase-Related Genes in Three Herpesviruses, Herpes Simplex Virus, Varicella-Zoster Virus, and Epstein-Barr Virus,”J. Virology63:450-455 (1989).
Springer, “Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm,”Cell76:301-314 (1994).
Tatemoto et al., “Isolation of a brain peptide identical to the intestical PHI (peptide HI),”FEBS Letters153:248-253 (1983).
Text Search and Abstract of U.S. Patents, done Apr. 23, 1996.
Zhu et al., “Mediation of Lung Metastasis of Murine Melanomas by a Lung-specific Endothelial cell Adhesion Molecule,”Proc. Natl. Acad. Sci. USA. 88:9568-9572 (1991).
Pasqualini Renata
Ruoslahti Erkki
Priebe Scott D.
The Burnham Institute
LandOfFree
Method of identifying molecules that home to a selected... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of identifying molecules that home to a selected..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of identifying molecules that home to a selected... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3971871